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Addenda 
Is Autophagy the Key Mechanism by Which the Sphingolipid Rheostat
Controls the Cell Fate Decision?
ABSTRACT
Sphingolipids are major constituents of biological membrane and some of them
behave as second messengers involved in the cell fate decision. Ceramide and sphingosine
1-phosphate (S1P) constitute a rheostat system in which ceramide promotes cell death and
S1P increases cell survival. We have shown that both sphingolipids are able to trigger
autophagy with opposing outcomes on cell survival. Here we discuss and speculate on
the diverging functions of the autophagic pathways induced by ceramide and S1P,
respectively.
CERAMIDE AND S1P BOTH TRIGGER AUTOPHAGY
The metabolism of sphingolipids is a dynamic process generating second messengers
such as ceramide and S1P.1 The formation of ceramide is followed by a deacylation to form
sphingosine, which is subsequently phosphorylated by sphingosine kinases (SK), leading
to S1P formation. It is now generally accepted that ceramide and S1P have contrasting
roles on the response to cell stress.2 Ceramide is associated with cell growth arrest and cell
death induction, whereas S1P stimulates proliferation and maintains survival in numerous
cell types.
Our group has investigated the correlation between sphingolipid metabolism, the
autophagic capacities and the cell signaling pathways; we showed that ceramide and S1P
are able to induce autophagy in a breast cancer cell line.3,4
First, we showed that ceramide could mediate tamoxifen-induced autophagy, which
represents a model of autophagic cell death.5 It was shown that tamoxifen induced an
increase of endogenous ceramide levels responsible for a robust accumulation of Beclin1
and an inhibition of Akt/PKB phosphorylation, which tend to increase the autophagic
response. In addition, we also showed that treatment by short permeant ceramide
(C2-ceramide) mimicked these effects. Accordingly, pharmacological inhibition of
endogenous long chain ceramide biosynthesis by fumonisin B1 (FB1), prevents autophagic
induction by tamoxifen. Interestingly, Kondo and colleagues have shown, that treatment
of glioma cells with C2-ceramide increased autophagy and cell death by activating Bnip3,
a proapoptotic mitochondrial protein.6 These modulatory effects on protein expression
appear to constitute three alternative steps for ceramide to regulate autophagy.
The fact that ceramide and S1P constitute a rheostat system involved in the control of
cell death, prompted us to investigate the role of S1P on autophagy. Surprisingly, we
observed that the increase of S1P levels after sphingosine kinase 1 overexpression is able to
induce autophagy.3 This S1P-induced autophagy correlates with the inhibition of the
mTOR activity (without alteration of Akt/PKB phosphorylation) and a moderate increase
in the amount of Beclin 1. In addition, SK1 activity increased during nutrient starvation,
and inhibition of SK1 by siRNA prevented autophagy and exacerbated cell death with
apoptotic hallmarks induced by starvation. These results suggest that autophagy is a novel
function of S1P in cell survival.
TWO DIFFERENT AUTOPHAGIC PROCESSES CONTROLLED BY SPHINGOLIPIDS?
The above observations reinforced the ambiguous involvement of autophagy in the cell
lifetime. However, some key differences were noted between ceramide and S1P-induced
autophagy that could account for the decision of the cell to survive or die. Distinctions
appear in the step of signaling pathway alteration (ceramide acts upstream of S1P), in the
amplitude of the autophagic response (ceramide could trigger a stronger response) and in
the nature of the stress (only SK
activity increased after starvation)
(Fig. 1).
Ceramide acts upstream of
S1P by inhibiting Akt/PKB
phosphorylation, which is associ-
ated with autophagy suppression
and reduction of cell viability.7,8
S1P acts only at the level of
mTOR, independently of the
PI3K arm, in a direct or indirect
manner, as suggested by the 
inhibition of phosphorylation of
mTOR substrates (p70S6K,
4E-BP1). Does this observation
mean that in comparison with S1P,
ceramide has a broad-spectrum
of targets potentially linked to
cell death induction.
Although Beclin 1 is a common
target for both sphingolipids, a
major difference appears. Only
ceramide induces a strong
accumulation of Beclin 1 (2.5 fold
higher than after S1P enhance-
ment, according to Fig. 6 of
Lavieu et al.3). Because the inter-
action between Bcl-2 and Beclin 1
is required to maintain autophagy
in a physiological range,9 it is tempting to speculate that the strong
increase of Beclin 1 induced by ceramide changes the ratio of Beclin
1/Bcl-2 in a range incompatible with survival. Moreover, it was
shown by Bektas et al.10 that the increase of SK activity is tightly
associated with the enhancement of Bcl-2 expression. This observa-
tion, in addition to the moderate accumulation of Beclin 1 after
SK1 overexpression seems to be compatible with the Bcl-2/Beclin 1
rheostat hypothesis. Does it mean that the autophagic response trig-
gered by S1P is gentler than ceramide-induced autophagy and com-
patible with cell survival? Interestingly, a fine analysis of the data from
Lavieu et al.3 (see Fig. 2), tends to support this suggestion, even
though the method used to induce autophagy by the two lipids is
different (treatment by exogenous short-chain ceramide for
ceramide-induced autophagy vs. enforced expression of SK1 for the
S1P-induced autophagy). The GFP-LC3 dot formation is lower in
the case of S1P-induced autophagy (approximately 1.6 fold lower
than after C2-ceramide treatment). The ceramide response seems to
be also faster than the S1P response (4 hours vs. at least one day).
However, this point would deserve further study by analyzing the
effect of ceramide and S1P on the interaction between Bcl-2 and
Beclin 1.
One of the major differences between the two responses is the
nature of the stress situation, since only S1P-induced autophagy
occurs after nutrient starvation. We have shown that starvation
induced both autophagy and an increase of SK activity. This last
point was equally observed in yeast suggesting a general role for SK
during the starvation response.11 We have shown that the
knock-down of SK1 expression by siRNA inhibits starvation-
induced autophagy and increased cell death. For this reason we
proposed that S1P is a mediator of starvation-induced autophagy
which is now well established as a survival mechanism.12
Surprisingly, the amount of endogenous ceramide during starvation
remained unchanged (from 15 min to 48 h) and the autophagic
response after inhibition of ceramide biosynthesis by FB1 treatment
was unaffected. These results suggest that ceramide is excluded from
the regulation of starvation-induced autophagy. Does it mean that
ceramide-induced autophagy and S1P-induced autophagy are
mutually exclusive responses? Study of enzymes that regulate the
balance between ceramide and S1P could be one of the ways to
resolve these questions.
While the above discussion deals with sphingolipids as second
messengers and their role in signal transduction, we should not forget
that these molecules are constituents of biological membranes and
that, because of their biophysical properties, modulate membrane
functions. For example it is now established that ceramide is respon-
sible for a negative curvature of the membrane.13 Moreover, it was
shown that alteration of ceramide biosynthesis results in changes of
the vacuole morphology in the yeast Saccharomyces cerevisiae.14
Additionally, studies have described a change in SK1 localization,
which is usually cytosolic. For example, SK1 is recruited to the
nascent phagosome in human macrophages during the phagocytosis
of mycobacterium tuberculosis.15 What is the significance of this
enzyme delocalization? Where is localized SK1 during autophagy? It
is an attractive possibility to contemplate that, in addition to its sig-
naling activity, ceramide and other lipids could play a structural role
in the autophagosome biogenesis. Progress in microscopy and the
development of fluorescent probes for sphingolipid trafficking
analysis need to be considered in order to identify the origin of the
autophagosome, an old and still unanswered question.16
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Figure 1. Hypothetical model for ceramide and S1P-induced autophagy and their consequences on cell fate. An
increase of endogenous ceramide promotes a robust accumulation of Beclin 1 and an autophagic response
associated with cell death. An increase of S1P level (after starvation) induces a mild accumulation of Beclin 1 and
promotes cell survival by inhibiting the induction of apoptosis.
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